Predictors of outcome in brief cognitive behavior therapy for schizophrenia

Schizophrenia Bulletin

Volumn 35, Issue 5, 2009, Pages 859-864

  Brabban, Alison ^a   Tai, Sara ^b   Turkington, Douglas ^c  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Carers; CBT; Insight; Psychiatric nurses; Psychosis; Psychosocial interventions

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DELUSION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE; PRIORITY JOURNAL; PROGNOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; AWARENESS; CASE MANAGEMENT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DELUSIONS; DRUG RESISTANCE; FEMALE; HUMANS; INSERVICE TRAINING; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; PSYCHIATRIC NURSING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, BRIEF; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; SOCIAL ADJUSTMENT;

EID: 69249150802     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp065     Document Type: Article

References (27)

1. Turkington D, Kingdon DG, Weiden PJ. Cognitive behavior therapy for schizophrenia. Am J Psychiatry. 2006;163:365-373.
2. Kingdon DG, Turkington D. Cognitive Therapy of Schizophrenia. New York, NY: Guilford; 2005.
3. Turkington D, Kingdon D, Rathod S, et al. Back to Life, Back to Normality: Cognitive Therapy, Recovery and Psychosis. Cambridge: Cambridge University Press; 2009.
4. National Institute of Clinical Excellence (NICE). Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). London:National Institute for Clinical Excellence; 2009.
5. Garety P, Fowler D, Kuipers E, et al. London-East Anglia randomized controlled trial of cognitive behavioural therapy for psychosis II: predictors of outcome. Br J Psychiatry. 1997;171:420-426.
6. Naeem F, Kingdon D, Turkington D. Predictors of response to cognitive behavior therapy in the treatment of schizophrenia: a comparison of brief and standard interventions. Cognit Ther Res. 2008;32:651-656.
7. Tarrier N, Yusupoff L, Kinney C, et al. A randomised controlled trial of intensive cognitive behaviour therapy for chronic schizophrenia. Br Med J. 1998;317:303-307.
8. Drury V, Birchwood M, Cochrane R, Macmillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial II: impact on recovery time. Br J Psychiatry. 1996;169: 602-607.
9. Turkington D, Kingdon D, Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry. 2002;180:523-527.
10. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand. 1978;(suppl 271):5-9.
11. David AS. Insight and psychosis. Br J Psychiatry. 1990;156: 798-808.
12. Haddock G, McCarron J, Tarrier N, Faragher B. Scales to measure dimensions of hallucinations and delusions: the psychotic symptoms rating scales (PSYRATS). Psychol Med. 1999;29:879-889.
13. Hansen L, Turkington D, Kingdon D, Smith P. Brief rating instrument for assessment of negative symptoms: derived from the Comprehensive Psychopathological Rating Scale (CPRS). Int J Psychiatry Clin Pract. 2003; 7:113-116.
14. Argyle M. The Psychology of Interpersonal Behaviour. Harmondsworth, UK: Penguin; 1990.
15. Dulewicz V, Higgs M. Emotional intelligence: managerial fad or valid construct? HenleyManagement College; 1998. Henley Working Paper 9813.
16. Schutte NS, Malouff JM, Hall LE, et al. Development and validation of a measure of emotional intelligence. Pers Individ Dif. 1998;25:167-177.
17. Safran JD, Segal ZV, Vallis TM, Shaw BF, Samstag LW. Assessing patient suitability for short-term cognitive therapy with an interpersonal focus. Cognit Ther Res. 1993;17:23-38.
18. Iacono WG, Beiser M. Where are the women in first-episode studies of schizophrenia? Schizophr Bull. 1992;18:471-480.
19. Moriarty PJ, Lieber D, Bennett A, et al. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr Bull. 2001;27:103-113.
20. Riecher-Rossler A, Hafner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr Scand. 2000;407:58-62.
21. Usall J, Araya S, Ochoa S, Busquets E, Gost A, Marquez M. Gender differences in a sample of schizophrenic outpatients. Compr Psychiatry. 2001;42:301-305.
22. Murray RM, van Os J. Predictors of outcome in schizophrenia. J Clin Psychopharmacol. 1998;18(suppl 1):2s-4s.
23. Lindamer-Laurie A, Lohr-James B, Harris-Jackuelyn M, Jeste-Dilip V. Gender, estrogen and schizophrenia. Psychopharmacol Bull. 1997;33:221-228.
24. Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull. April 9, 2008; doi:10.1093/schbul/sbn023.
25. Häffner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28:17-54.
26. Wessely S, Buchanan A, Reed A, Cutting J, Garety P, Taylor P. Actingondelusions I:prevalence. Br JPsychiatry. 1993;163:69-76.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: Author, 1994.